Cycloferon efficacy in treatment of upper respiratory tract infections : systematic review and meta-analysis
Medical scientific sources about randomized clinical trials of Cycloferon were studied as a single plot of 531 articles. AIM was to get the generalized cycloferon efficacy's assessment in comparison with basic therapies curing the otorhinolaryngologic diseases. Groups heterogeneity and responding parameters' variability were estimated also. Comparison groups were symmetric enough to annihilate end-point variabilities, so the results' interpretations were clear enough and vector of clinical effects was detectable. Comparison groups were integrated to increase statistical power of metaanalysis. In result, cycloferon additional administration in treatment of otorhinolaryngologic diseases added 25% to absolute and relative usefulness of medical intervention. Also cycloferon increased 3,5 times the chances of recovery and absence of recurrent exacerbation.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:84 |
|---|---|
| Enthalten in: |
Vestnik otorinolaringologii - 84(2019), 3 vom: 05., Seite 82-88 |
| Sprache: |
Russisch |
|---|
| Weiterer Titel: |
Klinicheskaia éffektivnost' tsikloferona pri infektsiiakh verkhnikh dykhatel'nykh puteĭ. Sistematicheskiĭ obzor i metaanaliz |
|---|
| Beteiligte Personen: |
Mazina, N K [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 06.11.2019 Date Revised 06.11.2019 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.17116/otorino20198403182 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM300954794 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM300954794 | ||
| 003 | DE-627 | ||
| 005 | 20231225103626.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||rus c | ||
| 024 | 7 | |a 10.17116/otorino20198403182 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1003.xml |
| 035 | |a (DE-627)NLM300954794 | ||
| 035 | |a (NLM)31486434 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a rus | ||
| 100 | 1 | |a Mazina, N K |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cycloferon efficacy in treatment of upper respiratory tract infections |b systematic review and meta-analysis |
| 246 | 3 | 3 | |a Klinicheskaia éffektivnost' tsikloferona pri infektsiiakh verkhnikh dykhatel'nykh puteĭ. Sistematicheskiĭ obzor i metaanaliz |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 06.11.2019 | ||
| 500 | |a Date Revised 06.11.2019 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Medical scientific sources about randomized clinical trials of Cycloferon were studied as a single plot of 531 articles. AIM was to get the generalized cycloferon efficacy's assessment in comparison with basic therapies curing the otorhinolaryngologic diseases. Groups heterogeneity and responding parameters' variability were estimated also. Comparison groups were symmetric enough to annihilate end-point variabilities, so the results' interpretations were clear enough and vector of clinical effects was detectable. Comparison groups were integrated to increase statistical power of metaanalysis. In result, cycloferon additional administration in treatment of otorhinolaryngologic diseases added 25% to absolute and relative usefulness of medical intervention. Also cycloferon increased 3,5 times the chances of recovery and absence of recurrent exacerbation | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Meta-Analysis | |
| 650 | 4 | |a Systematic Review | |
| 650 | 4 | |a chance ratio | |
| 650 | 4 | |a cycloferon | |
| 650 | 4 | |a end-points | |
| 650 | 4 | |a heterogeneity analysis | |
| 650 | 4 | |a meta-analysis | |
| 650 | 4 | |a otorhinolaryngologic diseases | |
| 650 | 4 | |a sensitivity analysis | |
| 650 | 7 | |a Acridines |2 NLM | |
| 650 | 7 | |a Interferon Inducers |2 NLM | |
| 650 | 7 | |a 10-carboxymethyl-9-acridanone |2 NLM | |
| 650 | 7 | |a X91E9EME19 |2 NLM | |
| 700 | 1 | |a Mazin, P V |e verfasserin |4 aut | |
| 700 | 1 | |a Khafisianova, R Kh |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Vestnik otorinolaringologii |d 1945 |g 84(2019), 3 vom: 05., Seite 82-88 |w (DE-627)NLM000085405 |x 0042-4668 |7 nnns |
| 773 | 1 | 8 | |g volume:84 |g year:2019 |g number:3 |g day:05 |g pages:82-88 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.17116/otorino20198403182 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 84 |j 2019 |e 3 |b 05 |h 82-88 | ||